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Both the tissue lactate dehydrogenase (LDH) isoen-
zyme pattern and total LDH activity were investigated
in a series of human uterine sarcomas and cell lines
derived from these tumors. Abnormal LDH isoenzyme
patterns characterized by shifts toward the muscle iso-
enzyme forms (LDH4 and 5) were found in some, but
not all, ofthe sarcomas. The tumors containing rhabdo-
myosarcomatous elements usually had normal or only
slightly altered LDH isoenzyme patterns. The LDH
LACTATE DEHYDROGENASE (LDH) is a ubiq-
uitous cellular enzyme found in 5 isoenzyme forms.
The 5 LDH isoenzymes are separable by electrophor-
esis and have been given numeric designations based
on their electrophoretic mobility; the isoenzyme
having the highest mobility toward the anode has
been designated as number 1. Each isoenzyme is a
tetramer composed of subunits coded by two different
genes, designated M (muscle) and H (heart). These
two polypeptides give rise to five possible tetrameric
forms: H4 (LDHI), H3M (LDH2), H2M2 (LDH3),
HM3 (LDH4), and M4 (LDH5). Abnormal LDH
isoenzyme distributions have been reported for a
variety of malignant tumors. In malignant tumors of
the genital and digestive tracts, there is a characteristic
shift of LDH isoenzymes to a predominance of mus-
cle LDH forms (LDH4 and 5), accompanied by a
decrease of the normally predominant heart types
(LDHI and 2). The ratio of LDH5 to LDH1 is often
reported as an indicator of the change in distribution
of isoenzymes in malignancies. Most malignancies
have a high value for the LDH5/LDH1 ratio when
compared with benign lesions or normal tissues. Total
LDH activity in malignancies is often elevated.1-5
Human uterine tumors have been shown to have
LDH isoenzyme patterns characterized by elevated
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isoenzyme patterns expressed by cultured cell lines
established from the uterine sarcomas, in general, re-
sembled those found in the primary tumors. These re-
sults suggest that the normal or near normal LDH iso-
enzyme distributions found in uterine sarcomas with
rhabdomyosarcomatous differentiation may be a poten-
tial characteristic which may be used for distinguishing
these tumors from other uterine sarcomas. (AmJ Pathol
1984, 116:85-93)
levels of LDH5 and LDH4. However, elevation of
total LDH activity has not been found consistently.5
Approximately 3 Wo of all malignant uterine tumors
are primary sarcomas. Because of their rarity, very
few investigations of their profiles have been under-
taken in comparison with the more widely studied
endometrial adenocarcinomas.
Recently, our laboratory had the opportunity to
study the morphologic, biochemical, and isoenzyme
characteristics of several human uterine sarcomas.
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Cultured cell lines have been established from some
of these uterine sarcomas. In this report we character-
ize the LDH isoenzyme patterns and total LDH activ-
ity for these human uterine sarcomas and the cell
lines derived from them.
Materials and Methods
Tissue Obtainment and Cell Culture
The uterus was received immediately after surgery,
and tumor tissue was collected sterilely as previously
reported.6 Representative sections of the tumor mass
and endometrial lining were embedded and processed
in the usual manner. Parallel tissue sections were
stained with Harris' hematoxylin/alcohol eosin and
special stains as appropriate. Transmission electron-
microscopic studies and immunohistochemical stain-
ing were performed in selected cases. Following the
histologic diagnosis being made by an attending sur-
gical pathologist, all sections were reviewed by Dr.
Siegal for correctness of diagnosis. The saved sterile
tissue was divided, and portions were used for LDH
analysis and for culturing. For cell culture, neoplastic
tissue was washed 3 times with Hanks' balanced salt
solution (HBSS) and incubated for 3 hours in a triple
enzyme preparation (0.1/o trypsin, 0.1/o hyaluroni-
dase, and 0.5070 collagenase). This treatment reduced
the tissue to small fragments and single cells. These
were plated onto plastic dishes containing either
CMRL-1066 medium or DMEM (Dulbecco's modi-
fied Eagle's medium) supplemented with 10%b fetal
bovine serum, glutamine, and antibiotics (GIBCO,
Grand Island, NY, and Sterile Systems, Logan, Utah).
Confluent cultures were established in 3-4 weeks and
were then subcultured once a week.
LDH Quantitation and Isoenzyme Analysis
To prepare the enzyme extract for LDH quantita-
tion and isoenzyme analysis from the uterine sar-
comas, we first minced a small portion of each tumor
with scissors and then disrupted the cells in distilled
water using a motor-driven Potter-Elvehjem homog-
enizer fitted with a Teflon pestle at 0 C. An equal
volume of 0.25 M sucrose-0.15 M NaCl solution was
added to the cell homogenate to increase the solubili-
zation of the muscle LDH forms and decrease their
nonspecific association with cellular debris.' For
studies on cultured cells, one or two plates (60 mm)
of confluent sarcoma cells were harvested by trypsini-
zation, washed once in DMEM containing 1007o
serum, and washed twice in saline (0.85%o sodium
chloride). Cells were lysed in 100 1l. of distilled water
for 30 minutes; then 100 jl of the sucrose-NaCl solu-
tion was added, followed by incubation for another
30 minutes. We kept homogenates of tumors and cul-
tured cells at room temperature to prevent breakdown
of the muscle type isoenzymes, which are unstable in
the cold. Cellular debris was pelleted by centrifuga-
tion at 15,000 rpm for 30 minutes. Approximately 10
,ul of the cell lysates were placed in the sample wells
of lO agarose gels. The commercially prepared
agarose gels used for isoenzyme analysis were either
Corning Special Purpose or Universal electrophoresis
films (Fisher Scientific, Pittsburgh, Pa). Isoenzymes
were electrophoresed on the Corning Special Purpose
agarose gels for 1.5 hours at 250 volts. Three hours of
electrophoresis at 250 volts was required for isoen-
zyme separation on the Universal gels. The electro-
phoresis buffer contained 50 mM Tris, 12 mM citrate,
and 25 mM barbital, pH 8.3. We detected isoenzymes
using a prepared stain obtained from Sigma Chemical
Company (St. Louis, Mo). After staining, the gels
were dried and scanned with a densitometer (Kontes
Fiberoptic) equipped with an integrator. The percent-
age of muscle subunit was calculated with the use of
the equation given by Stagg and Whyley4:
(LDH5) + 0.75(LDH4) +
0.5(LDH3) + 0.25(LDH2) x 100 = %0 M subunit
(LDH1-5)
where the terms in parentheses represent the percent-
age of each isoenzyme as determined by densitomet-
ric scanning.
To determine the total LDH activity, we measured
the rate of pyruvate reduction to lactate through the
coupled oxidation of reduced nicotinamide adenine
dinucleotide (NADH).R This was quantitated spectro-
photometrically by measuring the decrease in NADH
absorbance at 350 nm. One unit was defined as the
amount of enzyme which would oxidize 1 pmol of
NADH per minute at 37 C. The specific activity of
LDH was expressed as units/minute/milligram
protein. Protein was determined with the Bio-Rad
protein assay (Bio-Rad, Richmond, Calif). LDH
quantitation, isoenzyme analysis, and protein deter-
mination were performed on each cytosol preparation.
Results
Portions of seven human uterine sarcomas were
obtained at the time of surgery. A brief clinical sum-
mary of each case is presented in Table 1. A more de-
tailed characterization of Case 3 has been published.9
The pathology of the tumors was established by mi-
croscopic examination. The LDH isoenzyme patterns
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Table 1-Clinical Summary-Patients With Uterine Sarcomas















































4 drug (1 cycle) 3 months
* All ages in years; W, white, B, black.
t ESM, endolymphatic stromal myosis; MMMT, malignant mixed mullerian tumor; hetero, heterologous elements; homol, homologous ele-
ments; rhabdo, rhabdomyosarcoma (pure heterologous sarcoma); leiomyo, leiomyosarcoma (pure homologous sarcoma).
t Bleeding, postmenopausal vaginal (uterine) bleeding (NB: Case 1 - Menometrorrhagia).
§ All radiation therapy given by external beam; 4 drug, vincristine, adriamycin, cytoxin, and methotrexate; cis-plat, cis-platinum.
1I AWD, alive with disease; DWD, dead with disease; ADF, alive and disease-free.
were analyzed in fresh tissue from uterine sarcomas 2,
3, 4, 6, and 7. Multiple areas of the primary tumor in
Cases 6 and 7 and a pelvic metastasis in Case 7 were
also analyzed. Although the original tumors of Cases
1 and 5 were not available, isoenzymes were evaluated
in cell lines established from these tumors. Table 2 is
a summary of the LDH isoenzyme patterns of these
human uterine sarcomas. The LDH isoenzyme distri-
bution of normal endometrium is presented as a base-
line for comparison. The relative amounts of each
Table 2-LDH lsoenzyme Distribution and LDH Activity of Human Uterine Sarcomas and Normal Endometrium
Percent LDH isoenzyme LDH
Ratio quantitation
LDH5 LDH4 LDH3 LDH2 LDH1 % Muscle (units/min/mg
Sample (M4) (M3H) (M2H2) (MH3) (H4) subunit 4:1 5:1 protein)
Sarcoma 2 (n = 2)
Sarcoma 3 (n = 3)




a) n = 2
b) n = 2
c) n = 2
Sarcoma 7
Two different sites








Secretory (n = 3)








16 + 0.99 32 + 1.08
9 1.49 24 + 2.09
34 + 0.78 20 + 0.85
36 + 0.45 28 + 0.67




































34 + 0.58 35 + 1.54 23 1.23 7 0.62 1 0.42 74 24.1 23.7 2.29 0.15
23 1.60 33 + 2.07 29 1.23 12 0.24 2 0.38 66 15.2 10.8 2.30 0.06
33 + 2.47 33 + 0.98 23 + 0.86 9 1.71 2 0.91
10 + 0.62 21 + 3.98 32 + 3.99 24 1.50 11 4.46
5 0.02 17 0.01 36 0.33 27 0.26 15 0.25
72 16.1 16.1 4.64 + 0.22
48 2.0 0.9 2.44 0.31
43 1.1 0.3 0.95 0.16
LDH isoenzyme distributions were quantitated by densitometer scanning. For each tumor, several lanes were run simultaneously, stained
for LDH, and scanned. The mean values and standard errors are presented. Normal and secretory endometrium was obtained from patients
undergoing hysterectomy for nonmalignant conditions. The results shown above for the normal endometrium are the mean and standard
errors of LDH isoenzyme patterns obtained from several patients. Abbreviations for diagnosis are the same as used in Table 1. Total LDH
activity was quantitated by the procedure described in Materials and Methods. For the primary tumors, LDH activity was determined in dupli-
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Figure 1A-Agarose gel showing the LDH isoenzyme patterns of sarcoma 4 (MMMT, homologous type) (a and b) and normal endometrium
(c and d). There is a dramatic shift toward the muscle LDH forms (LDH 4 and 5) in the tumor when compared with the normal tissue. B -
LDH isoenzyme patterns of normal proliferative endometrium (a) and Sarcoma 3 (b) (a pure heterologous rhabdomyosarcoma). Note the simi-
larities between the LDH isoenzyme patterns of Sarcoma 3 and of normal endometrium.
isoenzyme were determined by scanning densitometry
of agarose gels containing isoenzymes separated by
electrophoresis. The ratios of LDH5 to LDH1 and of
LDH4 to LDH1 and the percentage of muscle subunit
are used as comparative measures of the degree of
shift toward the muscle-type isoenzymes.
Sarcomas 2 and 4, one region of Sarcoma 6 (b) and
all sampled portions of Sarcoma 7 showed distinctive
abnormal LDH isoenzyme patterns, each with a char-
acteristic shift toward the muscle LDH isoenzyme
(LDH4 and 5) forms. The ratios of LDH5 to LDH1
ranged from 2.13 to 23.69, an increase ranging from
2 to 23 times the ratio found in normal secretory
phase endometrium. Figure IA shows an agarose gel
with the LDH isoenzymes of Sarcoma 4 and normal
endometrium. From this gel, it is obvious that there
is a dramatic shift toward the muscle LDH forms in
the tumor (a, b) when compared with the normal tis-
sue (c, d).
The LDH isoenzyme distributions were investi-
gated in two different portions of the uterine sarcoma
and a pelvic metastasis from Case 7. Densitometric
profiles (Figure 2A) show dramatic shifts toward the
muscle LDH forms in all sites; however, each site has
a unique isoenzyme pattern. In contrast, the isoen-
zyme distributions of Sarcoma 3 and two sites from
Sarcoma 6 (a and c) had little or no shift toward the
muscle LDH forms (Table 2). The ratio of LDH5 to
LDH1 for Sarcoma 3 and Sarcoma 6 (c) was within
normal values. From the agarose gel shown in Figure
lB (b), it can be seen that the LDH isoenzyme pattern
obtained from Sarcoma 3 closely resembles that ob-
tained from proliferative phase endometrium (Figure
lB [a]).
LDH isoenzyme distributions for Sarcoma 6 were
determined in three different sites within the primary
tumor (designated a, b, and c). This sarcoma was
unique because adequate separation of LDH5 could
not be obtained (Figure 2B). It is possible that this is
an example of an electrophoretic variant form of
muscle LDH that has been reported to occur in hu-
mans; in most cases the muscle variant has a slower
mobility than normal. 10 The densitometric scans (Fig-
ure 2B) show that isoenzyme patterns from the three
AJP * July 1984




I I I I I
IIZ C
l 00ll
Figure 2A- Densitometric scans show-
ing the LDH isoenzyme patterns of two
different uterine sites (intraluminal [b]
and myometrial wall [c]) of Sarcoma 7
(leiomyosarcoma) and of a pelvic me-
tastasis (a). Note that each site has a
distinctive LDH isoenzyme pattern and
that each site displays obvious shifts
toward the muscle LDH forms when
compared with normal patterns, as dis-
played in Figure 1. B -Densitomet-
ric scans of three different sites (a, b,
and c) within the primary tumor of Sar-
coma 6 (MMMT, heterologous type). In
a, LDH1 and 2 are elevated, and a dis-
tinct LDH5 peak is not present. In b and
c, LDH5 is not resolved completely,
which indicates that LDH5 may be a
muscle variant of slower electrophoret-
ic mobility that has been demonstrated
to occur in humans. High levels of



















sites differ. The LDH isoenzyme pattern of site c re-
sembles that of normal endometrium. Site a is unique
in that there is not a distinct LDH5 peak, and there
is a significant elevation of the heart LDH forms
(LDHI and 2). The absence of an LDH5 peak may be
due to the overlapping electrophoretic mobilities of
LDH5 and 4 observed with this tumor. A marked
shift toward the muscle LDH forms with an increase
in the LDH5/1 ratio is found in site b. Small portions
of sites a, b, and c of Sarcoma 6 were transplanted
together at a single site into several nude mice, and
obvious tumor growth occurred within 1 month. The
histologic characteristics of the tumors in nude mice
resembled the original human sarcoma. The LDH
isoenzyme patterns obtained from one of the tumors
from a nude mouse is shown in Figure 3.- Both human
and mouse LDH forms are present. Although the per-
centages of the intermediate human LDH forms can-
not be determined accurately because of possible con-
tamination with mouse LDH forms, human LDH5
and 4 are clearly distinguishable and are high in rela-
tion to LDH1. In fact, the LDH5/1 ratio of the tumor
from the nude mouse resembles the ratio found in
portion b of the original uterine sarcoma (Table 3).
Table 4 presents the LDH isoenzyme distribution
found in cell lines established from the uterine sar-
comas. When possible, the LDH values of cultured
cells are compared with those of the original tumors.
The growth medium (CMRL or DMEM) and the
number of passages are indicated in the Table. From
recent studies (manuscript in preparation), we have
found that both the growth medium and the time in
culture can influence the LDH isoenzyme distribu-
tion. As with the original tumors, there were differ-
ences in the LDH isoenzyme patterns of the cultured
sarcoma cell lines. Altered LDH isoenzyme distribu-
tions were found in cell lines derived from Sarcoma
1 and early cultures of Sarcoma 2 and Sarcoma 4. The
LDH5/LDH1 ratios ranged from 2.38 to 26.61. Only
slight shifts in the LDH isoenzyme distributions were
found in a cell line derived from Sarcoma 5 and in
late cultures of both Sarcoma 3 (6 passages) and Sar-
coma 2 (9 passages). The LDH isoenzyme profile
from cultured Sarcoma 4 was slightly more abnormal
Vol. 116 * No. 1
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than that observed in the original tumor. Early cul-
tures of Sarcoma 2 also had patterns like those found
in the original tumor; but with increasing passages,
the isoenzyme pattern became less abnormal and
more like the LDH isoenzyme pattern of normal se-
cretory phase endometrium (Table 4). These findings
were not duplicated in the LDH patterns of early cul-
tures of Sarcoma 3, because the patterns observed in
the original tumor had much lower levels of the
LDH4 and 5 (Table 4). By Passage 6, the muscle LDH
forms had decreased, and the isoenzyme pattern
began to resemble secretory phase endometrium.
Finally, the total LDH activity was measured in
uterine sarcomas, in cell lines derived from these sar-
comas, and in normal endometrium (Tables 2-4). Vari-
ations of LDH activity in the normal endometrium
occurred with the phases of the menstrual cycle. Se-
cretory phase endometrium characteristically had
higher LDH activity levels than proliferative phase
endometrium. This has also been observed by other
investigators.11 Most of the primary sarcomas and cell
lines had normal or slightly elevated levels of LDH
activity. The pelvic metastasis of Sarcoma 7 and in
cultured cells derived from Sarcomas 1 and 4 had sub-
stantially higher levels than normal endometrium.
Although there were slight differences between the
LDH activities of the original tumors and cultured
cells of Sarcomas 2 and 3, the values were still within
the range found in normal endometrium. TWo sites of
Sarcoma 6, a and b, had similar LDH activities;
whereas site c had significantly lower levels. The
tumor grown in nude mice that was derived from Sar-
coma 6 (a, b, and c) had an intermediate LDH activ-
Figure 3-An agarose gel show-
ing the LDH isoenzyme pattern
obtained from a nude mouse
tumor derived from Sarcoma 6
(MMMT, heterologous type) and
the LDH isoenzymes obtained
from cultured mouse 3T3 cells.
The first two lanes are the LDH
patterns from the nude mouse
tumor, and the last lane is from
the 3T3 cells. Both human and
mouse LDH isoenzymes can be
detected in the nude mouse
tumor. Note that human LDH4
and 5 are elevated in relation to
LDH1.
ity. Regional differences in LDH activity were also
observed in Sarcoma 7, where both intraluminal and
intramyometrial tumor had similar levels, but the
pelvic extension had an elevated activity. It should be
pointed out that the protein content of cultured cells
may be abnormally high due to contaminating serum
proteins. This would result in lower LDH specific
activities. In addition, normal cells are present in
tumors and may contribute to measured LDH activ-
ities as well as the LDH isoenzyme patterns.
Discussion
This study evaluated the LDH isoenzyme patterns
and total LDH activities of a series of human uterine
sarcomas and cell lines derived from them. Altered
total LDH activity was not a consistent finding in
these tumors and cell lines. In fact, the levels of LDH
activity in most of the primary sarcomas and cell lines
were normal or only slightly elevated. The pelvic
metastasis of Sarcoma 7 and cultured cells from Sar-
comas 1 and 4 had very elevated LDH activities and
each of these also had extremely altered LDH iso-
enzyme distributions. In spite of this apparent associ-
ation between elevated LDH activity and altered
LDH isoenzyme patterns, no direct correlation could
be drawn between these two parameters, because in
most cases the isoenzyme patterns were altered but
the LDH activity remained normal (sarcomas 2, 5,
and 7 [uterine wall]).
Three different regions of tumor were obtained for
study from Cases 6 and 7. In addition to the differ-
ences between two of the samples from Case 7 noted
.....a .: i...S ...
(, iMOUSE33......
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a a 0,j, 4' above, substantial differences were found between the
co6:o , three regions of Sarcoma 6. Region a had no detect-
0=E-2 +1 0W-ffi o N = 0able LDH5 and had a very low LDH4/1 ratio; region7. _ b had a slightly elevated LDH5/1 ratio; region c had
,) 0 detectable LDH5 but had a low LDH5/1 ratio. These
observations are indications of heterogeneity in LDH
0
ClO) tX isoenzyme patterns in different regions of these pri-
.0 .2n5 mary tumors. A large amount of evidence from
a: O <°,, <human and animal tumors supports the concept ofw>. <tumor cell heterogeneity in regard to biochemical
C
markers as well as other features (for a review, see
Owens et all2). There are several possible explanations
C
co|'iI-| °l ' <nowhich may account for differences in LDH isoenzyme
Eamg coX patterns as well as total LDH activity. First, there may
IcoE <,, be several subpopulations of tumor cells comprising
0 V the tumor, each expressing a distinct, LDH isoen-
zyme pattern. Second, different regions of the pri-
c C 'J. mary tumor may contain varying proportions of
a) E I + o normal and malignant cells, each of which have a
o-.Q characteristic isoenzyme pattern. Third, there may be
varying degrees of inflammation and necrosis in
.50 different regions, and this could affect the LDH isoen-
Ea |E 0 = -I 6s zyme distribution.
2 E +1 Ij In this study alterations in LDH isoenzyme pat-coCN Cc,U- a) 3 0_ terns were observed in many of the uterine sarcomas
V .% 0E and the cell lines derived from them. Alterations of
.,I-°o LDH isoenzyme forms in uterine tumors have been
2 reported previously. Goldman and co-workers3 found
0 ,INt +1o 3 elevated LDH activity and higher proportions of
-Ja) E muscle LDH forms in a single mixed mullerian
Cn , ^< tumor, as compared with normal myometrium andso °0 c a leiomyoma. Stagg and Whyley4 studied 7 human
0) = ^ . .= uterine adenocarcinomas and 1 leiomyosarcoma.
High levels of LDH5 were found in six of the cases
0o 9 of adenocarcinoma; however, there were notable00No differences in the extent of the LDH isoenzyme alter-
CD IE ations between tumors. The LDH5/1 ratios ranged
_ oX from 0.47 to 52.0. Elevated LDH activity was found
E IDc0] in 4 of the 7 cases of adenocarcinoma. In the 1 case
of low-grade leiomyosarcoma both the isoenzyme
0 .< ^ n =-, o pattern and total LDH activity were found to be with-
C a) < n " in normal values. This contrasts with the clinically
co cn 2 Y I C aggressive leiomyosarcoma in our study, which had
0 'a E a@g, extremely altered LDH isoenzyme patterns.
ccm 3 c0 In our investigation of alterations of LDH isoen-
E zyme patterns in uterine sarcomas there were con-
E, X- , _ °, <,, siderable differences among the tumors, as evidenced
by the 0.39 to 24.0 range of the value of the LDH5/1
o) E 4, ,E o ratio. Abnormal LDH isoenzyme patterns character-0D)
.: i 0 0 | 2 ° zed by shifts toward the muscle isoenzyme forms
_j 0 O N 9D n(LDH4 and 5) were found in both of the mixed mul-
0C lerian tumors with homologous sarcomatous ele-
CDCOEo0 0coo gE E a ments (Cases 2 and 4), in all regions of the leiomyo-
co C a s~ ><sarcoma (Case 7), and in one of three regions of a
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mixed mullerian tumor with heterologous rhabdo-
myosarcomatous elements (Case 6 , region b). In the
cultured sarcoma cell lines distinctly altered LDH iso-
enzyme distributions were found in a cell line derived
from an endolymphatic stromal myosis (Case 1) and
in cell lines established from the two mixed mullerian
tumors with homologous elements (Case 4, and Case
2 in early passages). In contrast, near normal LDH
isoenzyme patterns were found in the pure rhabdo-
myosarcoma (Case 3) and in two of three regions of
a mixed mullerian tumor with heterologous rhabdo-
myosarcomatous differentiation (Case 6, region a and
region c). Cultured cells derived from the pure rhab-
domyosarcoma expressed near normal LDH patterns
in later passages, as did a cell line derived from
another mixed mullerian tumor with heterologous
rhabdomyosarcomatous elements (Case 5).
Although an increased expression of muscle LDH
isoenzymes has been reported for most tumors, there
are cases where this is not true. For example, non-
uterine rhabdomyosarcomas and hepatomas in hu-
mans have been found to have notable shifts of their
LDH isoenzyme distributions from muscle to heart
LDH forms.' This is in direct opposition to what is
observed in most other tumors1'3 and may reflect the
reversion to fetal type differentiation for these tissues.
Among the uterine sarcomas we have studied, tumors
without rhabdomyosarcomatous elements and low
passage cultures derived from them all demonstrated
elevated LDH5/1 ratios. In contrast, the low values of
the LDH5/1 ratio among the tumors and cultured
tumor cells were restricted to cases with rhabdomyo-
sarcomatous elements. Although no definitive conclu-
sion can be made at this time and further investiga-
tion is necessary, our results suggest that uterine
tumors with rhabdomyosarcomatous differentiation
express normal or near normal LDH isoenzyme pat-
terns and that this may be a characteristic of uterine
rhabdomyosarcomas which may be used to distin-
guish them from other uterine sarcomas.
References
1. Shapira F: Isozymes and cancer. Adv Cancer Res 1973,
18:77-153
2. Goldman RD, Kaplan NO: Alterations of tissue lactate
dehydrogenase in human neoplasms. Biochem Biophys
Acta 1963, 77:515-518
3. Goldman RD, Kaplan NO, Hall TC: Lactic dehydroge-
nase in human neoplastic tissues. Cancer Res 1964, 24:
389-399
4. Stagg BH, Whyley GA: Some characteristics of lactate
dehydrogenase isoenzymes in tumours of the female
genital tract. Clin Chim Acta 1968, 22:521-533
5. Okabe K, Hayakawa T, Hamada M, Koike M: Purifica-
tion and comparative properties of human lactate de-
hydrogenase isozymes from uterus, uterine myoma, and
cervical cancer. Biochemistry 1968, 7:79-90
6. Kaufman DG, Siegfried JM, Dorman BH, Nelson KG,
Walton LA: Carcinogen-induced changes in cultured
human endometrial cells, Human Carcinogenesis.
Edited by CC Harris, H Autrup. New York, Academic
Press 1983, pp 469-508
7. Starkweather WH, Spencer HH, Schwarz EL, Schoch
HK: The electrophoretic separation of lactate dehy-
drogenase isoenzymes and their evaluation in clinical
medicine. J Lab Clin Med 1966, 67:329-343
8. Wrobelski F, LaDue JS: Lactic dehydrogenase activity
in blood. Proc Soc Exp Biol Med 1955, 90:210-213
9. Siegal GP, Taylor LL, Nelson KG, Reddick RL, Frazelle
M, Siegfried JM, Walton LA, Kaufman DG: The char-
acterization of a pure heterologous sarcoma of the
uterus: Rhabdomyosarcoma of the corpus. Int J Gyne-
col Pathol 1983, 2:303-315
10. Mourant AE, Beckman L, Beckman G, Nilsson LO,
Tills 0: Erythrocyte lactate dehydrogenase variants in
the Icelandic and Swedish populations. Acta Genet
(Basel) 1968, 18:553-555
11. Spellman CM, Fottrell PF, Baynes S, O'Dwyer EM,
Clinch JD: A study of some enzymes and isoenzymes
of carbohydrate metabolism in human endometrium
during the menstrual cycle. Clin Chim Acta 1973, 48:
259-268
12. Owens AH Jr, Coffey DS, Baylin SB (eds): Thmor Cell
Heterogeneity: Origins and Implications. New York,
Academic Press, 1982
Acknowledgments
We acknowledge the technical assistance of Ms. Jane L.
Martin. We also thank Ms. Amanda Wright Durrill for
preparation of the manuscript.
